medEctoin® in Eye Care

Delivering a vision: Dry eyes, red eyes, allergic eyes – let medEctoin® transform them into healthy, comfortable eyes and change how your customers view the world.

Explore Scroll indicator

Strong Claims for Healthy &

Hydrated Eyes

Tear film stabilization, inflammation redution, healing support - these and more effects of medEctoin on human eyes have been proven in a variety of studies conducted by researchers all over the world

  • Quick Reduction of Symptoms Like Itching, Tearing and Irritation Within 30 Seconds. 

    adobestock_772565755.jpg

    medEctoin® instantly works against dry eye symptoms like itching, tearing and irritation within only 30 seconds. 

  • Reduces Inflammation of the Conjunctiva.

    adobestock_558844874.jpg

    medEctoin® has inflammation-reducing properties that help soothe irritated eyes, reducing redness and discomfort caused by dryness, environmental factors, or screen fatigue. 

  • Intense Moisturization and Prevention From Further Dehydration. 

    adobestock_230770829.jpg

    medEctoin® effectively retains moisture, providing long-lasting hydration to dry eyes, which is crucial for alleviating symptoms of dry eye syndrome. 

  • Enhances Tear Film Stability. 

    adobestock_558844874-1727785875.jpg

    medEctoin® improves the stability of the tear film, helping to maintain adequate moisture on the eye’s surface and reducing evaporation, which is essential for eye comfort. 

  • Supports Wound Healing After Ocular Surgeries and/or Injuries of the Eyes.

    medEctoin® supports the body’s natural healing processes by stabilizing cell membranes, which enhances the regeneration of skin and tissue after surgical procedures. 

Clinically Proven: 


medEctoin® in Eye Care

medEctoin® provides significant relief for dry and irritated eyes by stabilizing tear film and reducing inflammation. Its effect on dry, allergic and red eyes has been thoroughly investigated by the scientific community.

Improvement Of Every Dry Eye Symptom

Participants

65 patients, aged 18 and above, with mild to moderate dry eye disease.

Duration

28 days.

Method

Physicians assessed clinical signs of DED, conjunctival hyperemia, tear break-up time (TBUT), and tear secretion. Following treatment, investigators and patients judged the efficacy and tolerability.

Treatment

35 patients used medEctoin® Eye Drops and 30 patients used HA Eye Drops within their defined intended use and in accordance with their respective instructions for use.

Ask an Expert

Prof. Dr. med. Philipp Steven is a leading expert in ophthalmology, specializing in ocular surface disorders, dry eye disease, and corneal surgery. Based in Germany, he is a professor at the University of Cologne and has made significant contributions to research, clinical care, and education in eye health.

“medEctoin® is a perfect match for our mission and even for our key value namely innovation.”

Innomed

Management

Join The Success Story of medEctoin®: 


License Our Products Under Your Brand

Your logo could soon be featured on these products – and all in just 8 months. 
Learn more about claims and applications by clicking on the product of your choice.

Learn More About Our Products

Contact Our Sales Team

Flora Theves

Julian Spanke

Mansi Vats

Wael Al-Katmeh